RADX
Radiopharm Theranostics Limited American Depositary Shares
RADX
RADX
5 hedge funds and large institutions have $1.58M invested in Radiopharm Theranostics Limited American Depositary Shares in 2025 Q2 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, 1 reducing their positions, and 0 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
5
Holders Change
+2
Holders Change %
+66.67%
% of All Funds
0.07%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
–
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
UBS Group
Zurich,
Switzerland
|
$82.3K |
| 2 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
$37.1K |
Top Sellers
| 1 |
AAA
Affinity Asset Advisors
New York
|
$166K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
SCM
1
Silverarc Capital Management
Boston,
Massachusetts
| $870K | – | – | – |
|
|
RP
2
Regal Partners
Sydney, NSW,
Australia
| $422K | – | – | – |
|
|
AAA
3
Affinity Asset Advisors
New York
| $166K | -$135K | -28,965 | -45% |
|
|
4
UBS Group
Zurich,
Switzerland
| $82.3K | +$82.3K | +17,740 | New |
|
|
5
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| $37.1K | +$37.1K | +8,000 | New |
|